Literature DB >> 17318487

Isolation and partial characterization of antimicrobial compounds from a new strain Nonomuraea sp. NM94.

Boubekeur Badji1, Abdellah Mostefaoui, Nasserdine Sabaou, Ahmed Lebrihi, Florence Mathieu, Elisabeth Seguin, François Tillequin.   

Abstract

An actinomycete strain NM94 was isolated from a Saharan soil sample by a dilution agar plating method using chitin-vitamins B medium supplemented with penicillin. The strain presented the morphological and chemical characteristics of the genus Nonomuraea. On the basis of 16S rDNA analysis and physiological tests, this isolate was found to be quite different from the known species of Nonomuraea and might be new. The strain NM94 secreted several antibiotics on yeast extract malt extract glucose medium that were active against some Gram-positive bacteria, yeast, and fungi. The antibiotics were extracted with dichloromethane and detected by bioautography on silica gel plates using Mucor ramannianus and Bacillus subtilis as the test organisms. Among these antibiotics, a complex called 94A showed interesting antifungal activity. It was selected and purified by reverse-phase HPLC. This complex was composed of five compounds. Spectroscopic studies by infrared, mass, and (1)H NMR of the compounds were carried out. Initial results showed that these molecules differed from the known antibiotics produced by other Nonomuraea species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318487     DOI: 10.1007/s10295-007-0210-z

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   4.258


  20 in total

Review 1.  Antifungal antibiotics.

Authors:  M Gupte; P Kulkarni; B N Ganguli
Journal:  Appl Microbiol Biotechnol       Date:  2002-01       Impact factor: 4.813

2.  Semisynthetic derivatives of madurahydroxylactone and their antibacterial activities.

Authors:  L Heinisch; E Roemer; P Jütten; W Haas; W Werner; U Möllmann
Journal:  J Antibiot (Tokyo)       Date:  1999-11       Impact factor: 2.649

3.  [Selective isolation of actinomycetes of the genus Actinomadura from soil].

Authors:  O S Zakharova; G M Zenova; D G Zviagintsev
Journal:  Mikrobiologiia       Date:  2003 Jan-Feb

4.  FRESH ISOLATES OF ACTINOMYCETES IN WHICH THE PRESENCE OF SPOROGENOUS AERIAL MYCELIA IS A FLUCTUATING CHARACTERISTIC.

Authors:  K L Jones
Journal:  J Bacteriol       Date:  1949-02       Impact factor: 3.490

Review 5.  Overview of the lipid formulations of amphotericin B.

Authors:  Bertrand Dupont
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

6.  [Isolation of new species of the genus Actinomadura on selective media with rubomycin].

Authors:  N V Lavrova; T P Preobrazhenskaia
Journal:  Antibiotiki       Date:  1975-06

Review 7.  Bioautography in paper and thin-layer chromatography and its scope in the antibiotic field.

Authors:  V Betina
Journal:  J Chromatogr       Date:  1973-04-11

8.  Reclassification of Thermomonospora and Microtetraspora.

Authors:  Z Zhang; Y Wang; J Ruan
Journal:  Int J Syst Bacteriol       Date:  1998-04

9.  Mutactimycin PR, a new anthracycline antibiotic from Saccharothrix sp. SA 103. I. Taxonomy, fermentation, isolation and biological activities.

Authors:  Abdelghani Zitouni; Hadjira Boudjella; Florence Mathieu; Nasserdine Sabaou; Ahmed Lebrihi
Journal:  J Antibiot (Tokyo)       Date:  2004-06       Impact factor: 2.649

Review 10.  From natural products to clinically useful antifungals.

Authors:  David Barrett
Journal:  Biochim Biophys Acta       Date:  2002-07-18
View more
  2 in total

1.  Successive nonstatistical and statistical approaches for the improved antibiotic activity of rare actinomycete Nonomuraea sp. JAJ18.

Authors:  Polpass Arul Jose; Solomon Robinson David Jebakumar
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

Review 2.  Actinobacteria Derived from Algerian Ecosystems as a Prominent Source of Antimicrobial Molecules.

Authors:  Ibtissem Djinni; Andrea Defant; Mouloud Kecha; Ines Mancini
Journal:  Antibiotics (Basel)       Date:  2019-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.